Swiss National Bank Bei Gene, Ltd. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$131.8 - $202.24 $65,900 - $101,120	500 Added 0.39%	128,785 $17.4 Million
Q2 2022 Aug 09, 2022	SELL	$121.11 - $216.05 $72,666 - $129,630	-600 Reduced 0.47%	128,285 $20.8 Million
Q1 2022 May 09, 2022	BUY	$146.52 - $269.56 $2.33 Million - $4.29 Million	15,900 Added 14.07%	128,885 $24.3 Million
Q2 2021 Aug 06, 2021	SELL	$292.75 - $367.01 $1.72 Million - $2.15 Million	-5,871 Reduced 4.94%	112,985 $38.8 Million
Q1 2021 May 07, 2021	BUY	$260.64 - $382.12 $2.35 Million - $3.44 Million	9,000 Added 8.19%	118,856 $41.4 Million
Q4 2020 Feb 05, 2021	SELL	$221.31 - $316.61 $10.8 Million - $15.5 Million	-48,994 Reduced 30.84%	109,856 $28.4 Million
Q3 2020 Nov 09, 2020	BUY	$189.18 - $286.44 $576,999 - $873,642	3,050 Added 1.96%	158,850 $45.5 Million
Q2 2020 Aug 05, 2020	BUY	$123.9 - $195.41 $706,230 - $1.11 Million	5,700 Added 3.8%	155,800 $29.4 Million
Q1 2020 May 08, 2020	BUY	$121.84 - $173.19 $2.92 Million - $4.16 Million	24,000 Added 19.03%	150,100 $18.5 Million
Q4 2019 Feb 06, 2020	SELL	$115.78 - $208.34 $740,992 - $1.33 Million	-6,400 Reduced 4.83%	126,100 $20.9 Million
Q3 2019 Nov 12, 2019	BUY	$120.61 - $148.29 $205,037 - $252,093	1,700 Added 1.3%	132,500 $16.2 Million
Q2 2019 Aug 02, 2019	BUY	$113.99 - $146.86 $1.15 Million - $1.48 Million	10,100 Added 8.37%	130,800 $16.2 Million
Q1 2019 May 10, 2019	BUY	$122.82 - $151.83 $171,948 - $212,562	1,400 Added 1.17%	120,700 $15.9 Million
Q4 2018 Feb 13, 2019	BUY	$107.01 - $175.15 $12.8 Million - $20.9 Million	119,300 New	119,300 $16.7 Million

Others Institutions Holding BGNE

# of Institutions

250

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$2.01 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.23 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$986 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$948 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$706 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.8B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account